Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts

Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts

The utility of plasma amyloid beta (Aβ) and tau levels for the clinical diagnosis of Alzheimer’s disease (AD) dementia has been controversial. The main objective of this study was to compare Aβ42 and tau levels measured by the ultra-sensitive immunomagnetic reduction (IMR) assays in plasma samples c...

Full description

Bibliographic Details
Main Authors: Lih-Fen Lue, Marwan N. Sabbagh, Ming-Jang Chiu, Naomi Jing, Noelle L. Snyder, Christopher Schmitz, Andre Guerra, Christine M. Belden, Ta-Fu Chen, Che-Chuan Yang, Shieh-Yueh Yang, Douglas G. Walker, Kewei Chen, Eric M. Reiman
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
plasma
amyloid β
tau
Alzheimer’s disease
immunomagnetic reduction assay
Online Access:http://journal.frontiersin.org/article/10.3389/fnagi.2017.00226/full

Internet

http://journal.frontiersin.org/article/10.3389/fnagi.2017.00226/full

Similar Items